Details for Patent: 5,627,178
✉ Email this page to a colleague
Summary for Patent: 5,627,178
| Title: | 2-methyl-thieno-benzodiazepine |
| Abstract: | 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1## |
| Inventor(s): | Chakrabarti; Jiban K. (Camberley, GB2), Hotten; Terrence M. (Hants, GB2), Tupper; David E. (Reading, GB2) |
| Assignee: | Lilly Industries Limited (Basingstoke, GB2) |
| Application Number: | 08/387,997 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,627,178
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,627,178
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0454436 | ⤷ Sign Up | CA 2001 00042 | Denmark | ⤷ Sign Up |
| European Patent Office | 0454436 | ⤷ Sign Up | C970015 | Netherlands | ⤷ Sign Up |
| European Patent Office | 0454436 | ⤷ Sign Up | SPC/GB96/058 | United Kingdom | ⤷ Sign Up |
| European Patent Office | 0454436 | ⤷ Sign Up | 97C0012 | Belgium | ⤷ Sign Up |
| European Patent Office | 0454436 | ⤷ Sign Up | 9/1997 | Austria | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
